The wearable activity technology and action-planning trial in cancer survivors: Physical activity maintenance post-intervention |
| |
| Affiliation: | 1. School of Health and Human Performance, Dublin City University, Dublin, Ireland;2. Institute for Health Research, University of Notre Dame, Western Australia, Australia;3. School of Psychology, Curtin University, Bentley, Western Australia, Australia;4. Australian Centre for Precision Health, School of Health Sciences, University of South Australia Cancer Research Institute, Adelaide, Australia;5. St John of God Subiaco Hospital, Subiaco, Western Australia, Australia;6. St John of God Murdoch Hospital, Murdoch, Western Australia, Australia;7. Hollywood Private Hospital, Nedlands, Western Australia, Australia;8. School of Medicine, University of Western Australia, Crawley, Western Australia, Australia;9. Women Centre, West Leederville, Western Australia, Australia |
| |
| Abstract: | ObjectivesThe study objective was to assess whether moderate-to-vigorous intensity physical activity (MVPA) change in cancer survivors (n = 68, mean age = 64 years) was maintained 12-weeks following the Wearable Activity Technology and Action Planning (WATAAP) intervention. Secondary aims were to assess the effects of the intervention on blood pressure (BP) and body mass index (BMI), and to explore group differences between baseline and 24-weeks.DesignRandomized controlled trial.MethodsMVPA and sedentary behaviour were assessed using an accelerometer at baseline, the end of the intervention (12-weeks), and at 24-weeks. Generalised linear mixed models with random effects were used to examine between-group and within-group changes in MVPA, sedentary behaviour, BP and BMI.ResultsMVPA was significantly higher in the intervention group compared with the control group at 24-weeks following adjustment for known confounders (141.4 min/wk. (95% CI = 9.1 to 273.8), p = 0.036). At 24-weeks participants in the intervention group had maintained their increased levels of MVPA (change from 12-weeks = 8.8 min/wk.; 95% CI = −43 to 61; p = 0.74). The reduction in MVPA in the control group over the first 12-weeks was also maintained at 24-weeks (5.4 min/wk.; 95% CI = −3.6 to 4.6; p = 0.80). Secondary outcomes did not differ between groups at 24-weeks.ConclusionsOur results suggest distance-based interventions using wearable technology produce increases in MVPA that endure at least 12-weeks after the intervention is completed. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
